In a specimen-matrix comparison (n=25), qualitative GFAP/d-dimer classification was concordant across plasma, venous whole blood, and capillary whole blood.<h4>Conclusions</h4>The updated LVOne assay enables simultaneous biomarker-based identification of both LVO and ICH in suspected stroke patients. The gene discussed is GFAP; the disease is stroke disorder.